Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds

Ina Vorberg, Roberto Chiesa

Research output: Contribution to journalReview articlepeer-review

Abstract

Prion diseases are devastating neurodegenerative disorders for which no drugs are available. The successful development of therapeutics depends on drug screening platforms and preclinical models that recapitulate key molecular and pathological features of the disease. Innovative experimental tools have been developed over the last few years that might facilitate drug discovery, including cell-free prion replication assays and prion-infected flies. However, there is still room for improvement. Animal models of genetic prion disease are few, and only partially recapitulate the complexity of the human disorder. Moreover, we still lack a human cell culture model suitable for high-content anti-prion drug screening. This review provides an overview of the models currently used in prion research, and discusses their promise and limitations for drug discovery.

Original languageEnglish
Pages (from-to)28-38
Number of pages11
JournalCurrent Opinion in Pharmacology
Volume44
DOIs
Publication statusPublished - Feb 2019

Fingerprint Dive into the research topics of 'Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds'. Together they form a unique fingerprint.

Cite this